Loading...
Chemical structure of Irpagratinib

GC73671

Irpagratinib

Also known as N-[(3S,4S)-3-[[6-(2,6-difluoro-3,5-dimethoxyphenyl)-8-(3-methoxy-3-methylazetidin-1-yl)pyrido[3,4-d]pyrimidin-2-yl]amino]oxan-4-yl]prop-2-enamide

Irpagratinib (ABSK011) is an orally active inhibitor of fibroblast growth factor receptor (FGFR) tyrosine kinase, targeting to FGFR4 (IC50<10 nM)

ChemicalCAS2230974-62-4MW570.59FormulaC28H32F2N6O5
CAS number
2230974-62-4
Molecular weight
570.59
Formula
C28H32F2N6O5
Solubility
DMSO : 100 mg/mL (175·26 mM; Need ultrasonic)
InChIKey
PGRHEHZIRYNZDV-FUHWJXTLSA-N
Catalogue number
GC73671
Brand
GLPBIO
Computed properties PubChem CID 135181440 · XLogP 2.9 · TPSA 120 Ų · H-bond donors 2
XLogP
2.9
TPSA
120 Ų
H-bond donors
2
H-bond acceptors
12
Rotatable bonds
9
Heavy atoms
41

SMILES CC1(CN(C1)C2=C3C(=CC(=N2)C4=C(C(=CC(=C4F)OC)OC)F)C=NC(=N3)N[C@@H]5COCC[C@@H]5NC(=O)C=C)OC

Computed descriptors from PubChem (CID 135181440), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.